GlassScriptPhysician profile
Mohammad Junayed Khan
NPI 1669979563
$5,870.42
in general payments reported to CMS, 2019-2025
18 companies · $2,940 in 2025
The $2,940 reported for 2025 was more than what 93% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,004 · 2023: $1,377 · 2024: $550 · 2025: $2,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,239 · Food and Beverage: $1,498 · Travel and Lodging: $1,090 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,239.17 |
| Food and Beverage | $1,497.91 |
| Travel and Lodging | $1,089.84 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,286.19 | 2024-2025 | Amnioexcel, Integra, Primatrix |
| Prodigy Surgical Distribution, INC. | $1,095.76 | 2023-2024 | |
| Treace Medical Concepts, INC. | $949.02 | 2022-2025 | |
| Kerecis Limited | $694.56 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Arthrex, INC. | $200.40 | 2023 | |
| Paratek Pharmaceuticals, INC. | $183.30 | 2022-2025 | Nuzyra |
| Stryker Corporation | $120.14 | 2022 | |
| Novo Nordisk INC | $64.14 | 2025 | |
| Merck Sharp & Dohme LLC | $41.29 | 2025 | Gardasil 9, Capvaxive |
| Advanced Oxygen Therapy INC. | $38.90 | 2025 | Topical Oxygen Chamber For Extremities |
| Zimmer Biomet Holdings, INC. | $35.10 | 2025 | Tapestry |
| Globus Medical, INC. | $30.51 | 2025 | Senza |
| Bioventus LLC | $28.44 | 2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $24.67 | 2024 | Collagenase Santyl |
| Lexicon Pharmaceuticals, INC. | $22.23 | 2023 | Inpefa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $22.20 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $16.94 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.63 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.